Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

South Africa

MeCRU Clinical Research Unit, Ga-Rankuwa

Newtown Clinical Research Centre, Johannesburg

Be Part Research, Paarl